Category: Global Control

How Britain Turned America into a Passive Tax Farm

This post by Guy Cihi, a contributor to the American Intelligence Media

The factual events underpinning this version of American history are drawn from conventional history books, expository articles, and personal diaries. References are provided below. The difference between this telling and the history taught in American public schools is that the intentions of the actors described herein are more logical to the facts.

The facts suggest that it was the Crown itself that organized and financed Washington’s Continental Army. Without the Crown’s support there would be no US Federal Government and no Rothschild Central Bank in America today. Corrupt Federal Governments and Central Banks are how the Crown controls and enslaves its colonies. This article outlines how the Crown executed its plans to give the American Colonies the false impression of independence whilst maintaining control through a newly established, corrupt Federal Government, a Constitution that agents of the Crown drafted, and soon enough, a foreign-owned Central Bank.

The Actual War

In 1778 France and England declared war. This war is called the Bourbon War in Britain and the Anglo-French War in France.  The beleaguered and bankrupt King Louis the XVI went all in on this war. Sadly it was a war that he would soon lose. Louis XVI would be the last king of France and he would pay for his defeat with his head. Americans are still paying for his defeat thanks to fiat debt enslavement. Louie’s failure ushers in the French Revolution; another British masterpiece of skullduggery, and gives birth to the French Republic under Napoleon.

British King George III was only just beginning to apply the Crown formula of divide and conquer among England’s commodity-rich colonies scattered about the world. The Crown’s enduring global domination can be directly attributed first and foremost to its central banking scheme; secondly to its Hegelian political deceptions, and thirdly to its advanced weaponry obtained through intellectual property theft.

Key Players Set the Trap

In 1778, American “Ambassador” Benjamin Franklin was living high with Marie Antionette and Louis in the palace at Versailles. In return for King George’s many indulgences and gifts, Franklin negotiated disadvantageous terms for the Colonies in every treaty he negotiated. In 1778, Franklin’s mission at Versailles was to convince King Louis XVI to participate in the American revolution. Franklin’s stay at Versailles was bankrolled by agents of King George III. Living descendants of first-hand witnesses attest to Franklin’s clandestine meetings with Crown agents at Montreal’s Hôtel Pierre du Calvet. This author has stayed in the same room Franklin used for his secret meetings.


The photo above shows hundreds of skeletons unearthed in Franklin’s London townhouse basement. These tiny tortured skeletons were found during the 1998 renovations of Franklin’s London townhome; the home provided to Franklin by the Crown. Was Franklin a practicing Satanist in addition to being a loyal servant of the Crown?

After George Washington’s fake 1776 “victory” at Trenton, Franklin was finally able to get a deal with Louis XVI whereby France would extend the Colonists credits with which to “pay” for French mercenary soldiers, war material, and the naval harassment of British ships. In return, the Colonists were to keep Britain bogged down while France assembled a naval fleet for the invasion of the Crown’s super-rich sugar colony, Jamaica. Remember, all wars are commodity wars. 

Louis XVI was being systematically deceived into believing that his navy and marines could wrest the rich sugar colony from the Crown. If France’s Jamaican attack had been successful, it would have diverted about 20 percent of King George’s free cash flow directly into Louis’s near-empty coffers. Louis took the bait and the British trap was set.

Propping up Washington and His Continental Army

By 1777 Britain was well along in implementing its plans to “lose” the unprofitable American Colonies whilst at the same time deceive Louis XVI into believing his warships and naval tactics were superior to those of the British navy.  This was not an easy thing to accomplish because Washington’s Army was even more tattered than the rotting barnacle-encrusted hulls of the French warships. 

The only real problem the British ever faced in the Colonies were the highly effective independent militias that were kicking British and Hessian asses all up and down the coastline. These guerrilla attacks changed the minimal cash flow coming in from the American Colonies into annual losses. Had Washington’s Continental Army fallen apart as expected in January of 1777, the independent militias would have gained more power and the British plans to exit without loss of control would likely have been set back several decades.  

It became essential for the Crown to step in to maintain the impression of a viable Continental American army so the Crown would have a single corrupt counterparty to negotiate peace terms with. In the winter of 1776-77, the only way to accomplish that was for the Crown to feed, clothe, and pay the ragtag Continental Army as quickly as possible.  This explains why thousands of new leather boots, woolen garments, tons of food, booze, cash money, and gunpowder were all stockpiled and left practically unguarded for the Americans to take in Trenton, New Jersey on December 26, 1776.

Not a single American died in the fake Battle of Trenton.  Most of the 22 Hessian casualties were officers because, well, dead men tell no tales.  Autopsies may likely reveal the Hessian officers were shot in the back by pissed-off Hessian mercenaries who must have quickly realized just why their sentries and guard posts had been recalled the night before, and why the report of an approaching rebel force was ignored by their commander.

After feeding, paying, and clothing his ragged Continental Army with the loot that British General Howe had so kindly stockpiled in Trenton, Washington set about thwarting French Marquis de Lafayette’s efforts to attack the British at their weakest points.  Instead of actually fighting the British, Washington only begged the French king for more credits with which to “pay” for more materials and naval harassment of British ships. Washington also kept himself busy working on fake plans to not attack New York City.  It seems that General Washington never attacked anywhere that he wasn’t invited to attack.  The few successful Colonial attacks, such as the Battle of Saratoga, were led by militiamen under the command of local Patriot heroes – the kind of men Washington was put in place to undermine.

Faking Not One But Two Critical Defeats

By 1780, the British plans were in the final stage and Lord Cornwallis was ready to pretend to lose the ground war to Lafayette and the French mercenaries. Oh right, George Washington was there too. The place chosen for this was Yorktown, a desolate location that is practically good for nothing even to this day. Despite the narcissism of Americans, this British false flag was entirely orchestrated for the benefit of King Louis XVI. The purpose of the fake defeat at Yorktown was to suck Louis further into the British trap – a trap that would ultimately cost Louis and his young wife Marie their heads.  

The fake British defeat at Yorktown gave Louis XVI the impression that his French army and navy had beaten the British army and navy at the Battles of Yorktown and the Chesapeake. In fact, the two battles were complete farces. Cornwallis purposefully positioned his fort on the wrong side of the river to make it easy for the French mercenaries to drop mortar rounds on top of it. The British warships sent from New York to engage the French blockade purposefully avoided sinking any French ships and then, inexplicably “ran away” back to New York.

The French warships were loitering in the Chesapeake, just off Yorktown, with their meters running-up charges the Colonists would soon regret having incurred. The French ships were there to blockade Lord Cornwallis from receiving British resupply from the sea. On the morning of September 5, 1781, the French ships were caught completely unaware and at anchor by multiple British warships that had come down from New York. Instead of sinking the French warships as they lay defenseless at anchor, British Commander Thomas Graves ordered his warships back out to open sea, giving French Admiral Compte de Grasse four hours to onboard his sailors; weigh anchors, and set out to engage the, oh so very kind British.

The Battle of the Chesapeake was short and indecisive. After a couple of hours, the British “escaped” to the north. The French did not pursue.  Why?  Because their old ships were 20 percent slower than the newer British ships.  At Yorktown, it was made to appear as if the French had defeated the British both on land and at sea.  No historian can explain these things logically and so a wide variety of unsatisfying excuses are given instead. How were the vastly superior British army and navy both defeated at Yorktown?  The logical answer is that they were not defeated. The battles were pantomimes and part of a trap designed to entice King Louis XVI further along in his plan to invade Jamaica to take the Crown’s super-rich sugar plantation away from King George III.

The Set Up is Complete

Following the false “victories” at Yorktown, French Admiral Compte de Grasse sailed his rotting French fleet back to the Caribbean to prepare for the coming invasion of Jamaica. Meanwhile, the Crown moved ahead with its plans to establish a controlled Continental Congress that would ratify a Constitution that would enable a Rothschild central bank. Crown loyalists including Hamilton, Adams, and others were paid to prepare competing (Hegelian dialectic) drafts of an American Constitution. The final document would give the impression of being hard fought for through heated debate but in truth the final Constitution enabled the Crown’s plans.

Fake Battles – Fake Treaties

Regardless of what has been reported about the peace treaties, the Crown gave away nothing, and it did not surrender after Yorktown. None of the several treaties that were signed ever required the Crown to abandon any of its rights, claims, and properties within the 13 Colonies. What actually happened was Crown loyalists Franklin and Lee negotiated America’s conditional surrender to the Crown. The American’s conditional surrender is made clear in the first Treaty of Paris, a document that simply altered the form of the Crown’s dominion over the 13 Colonies. The only thing the American Colonists actually “won” were some off-season whaling concessions along the coast of Greenland. For his bungling performance, George Washington was rewarded with King George’s personal commendation and support for becoming America’s first President.

Instead of multiple policed territories, the newly united states became a federally managed, semi-autonomous tax farm.  The Treaty of Paris transferred the Crown’s costs to police the colonies to the colonists, and within just a few years the Crown’s investment in the colonies was returned to marginal profitability.  Remember, the only valuable commodity coming out of America at that time was tobacco. The cotton gin wasn’t invented until 1794 and despite efforts to find it, there was almost no gold or silver.

The Real Battle Royale

Seven months after Admiral Compte de Grasse’s “victory” in the Battle of the Chesapeake, the French and British fleets met in the Caribbean in what is known as the great Battle of the Saintes. Compte de Grasse suffered a humiliating defeat. This time it was British Admiral Rodney who literally sailed circles around the slower French warships, pounding them with cannon fire from all directions. The absolute French defeat at the Saintes marked the end of Louis XVI’s reign, and the end of the French monarchy.

In surrendering to the British; along with many more of his assets, Louis XVI was required to transfer his Colonial receivables to King George.  In a subsequent British-American treaty, the Colonies were forced to accept the transfer of their war debts from Louis to King George’s Crown Bank of England. With that transfer, Americans became Crown debt slaves in perpetuity. 

Deception and Treachery

It was Commander Graves’ deceptive tactics at the Battle of the Chesapeake in September 1781 that tricked the French into believing their barnacle-encrusted old oaken warships had a chance of prevailing against the much newer and faster British copper-clad warships. That deception may well be the Crown’s greatest success in mind control, possibly right up there with the Crown virus of 2020, and the WTC “terrorist attack” on September 11, 2001.

Sadly for the once-again outplayed Americans, their surrender to the Crown initiated formation of a corrupt central government, a Rothschild central bank, and an insurmountable mountain of fiat national debt. It would be unfair to describe Washington, Franklin, Hamilton, Adams, and so many others as actual traitors, because there was no actual America at the time to be traitorous to. The concept of American national patriotism was another British mind game created later during the War of 1812 and specifically for the purpose of further increasing the national fiat debt.

Were There Were No Patriot Heroes?

There were a few brave and true American patriots alive at the end of the 1700s. Men like Jefferson, Stephen and Burr. These men gave us the Bill of Rights, the only American legal document that actually does protect Americans from total domination by the Crown. Until such time that Americans wake up and turn against the U.S. corporation acting in their name, the Crown will continue to rob and pillage America’s wealth. 

.


References

  • Allison, David K; Ferreiro, Larrie D, eds. (2018). The American Revolution: A World War. Smithsonian Institution. ISBN 9781588346599.
  • Ayling, Stanley Edward (1972). George the Third. London: Collins.
  • Barros, Carolyn A.; Smith, Johanna M. (2000). Life-writings by British Women, 1660–1815: An Anthology. UPNE. ISBN 978-1-55553-432-5. Retrieved 17 February 2016.
  • Bemis, Samuel Flagg (2012). The Diplomacy of the American Revolution. Read Books Ltd. ISBN 9781447485155.
  • Berenger, Jean (1997). A History of the Habsburg Empire 1700–1918. New York: Longman. ISBN 0-582-09007-5.
  • Black, Jeremy (2006). George III America’s Last King. Yale University Press. ISBN 9780300117325.
  • Blanning, Timothy (1996). The French Revolutionary Wars. New York: Oxford University Press. ISBN 0-340-56911-5.
  • Boromé, Joseph (January 1969). “Dominica during French Occupation, 1778–1784”. The English Historical Review. JSTOR 562321.
  • Chartrand, René (2006). Gibraltar 1779–83: The Great Siege. Osprey Publishing. ISBN 978-1-84176-977-6. Retrieved 16 November 2015.
  • Colomb, Philip (1895). Naval Warfare, its Ruling Principles and Practice Historically Treated. London: W. H. Allen. OCLC 2863262.
  • Dull, Jonathan R (2009). The Age of the Ship of the Line: The British & French Navies, 1650–1815. Seaforth Publishing. ISBN 9781473811669.
  • Grainger, John D (2005). The Battle of Yorktown, 1781: A Reassessment. Boydell Press. ISBN 978-1-8438-3137-2.
  • Greene, Jack P; Pole, J.R, eds. (2008). A Companion to the American Revolution. John Wiley & Sons. ISBN 9780470756447.
  • Falkner, James (2009), Fire Over The Rock: The Great Siege of Gibraltar 1779–1783, Pen and Sword, ISBN 9781473814226
  • France, Kingdom of; United States of America (1788). “Treaty of Alliance”. The Avalon Project, Yale Law School. Retrieved 24 August 2020.
  • Glascock, Melvin Bruce (1969). “New Spain and the War for America, 1779-1783”. LSU Historical Dissertations and Theses, 1590. Louisiana State University. Retrieved 20 August 2020.
  • Hagan, Kenneth J (16 October 2009). “The birth of American naval strategy”. In Hagan, Kenneth J.; McMaster, Michael T; Stoker, Donald (eds.). Strategy in the American War of Independence: A Global Approach. Routledge. ISBN 978-1-134-21039-8.
  • Jackson, Kenneth T; Dunbar, David S. (2005). Empire City: New York Through the Centuries. Columbia University Press. ISBN 978-0-2311-0909-3.
  • Hardman, John (2016). The Life of Louis XVI. Yale University Press. ISBN 9780300220421.
  • Harvey, Robert (2004). A Few Bloody Noses: The American Revolutionary War. Robinson. ISBN 9781841199528.
  • Ketchum, Richard M (1997). Saratoga: Turning Point of America’s Revolutionary War. New York: Henry Holt. ISBN 9780805061239. OCLC 41397623. (Paperback ISBN 0-8050-6123-1)
  • Lavery, Brian (2009). Empire of the seas: how the navy forged the modern world. Conway. ISBN 9781844861095.
  • Kochin, Michael S; Taylor, Michael (2020). An Independent Empire: Diplomacy & War in the Making of the United States. University of Michigan Press. ISBN 9780472054404.
  • Mahan, Alfred T (1957). The Influence of Sea Power Upon History, 1660–1783. New York: Hill and Wang.
  • Mahan, Alfred T (1898). Major Operations of the Royal Navy, 1762–1783: Being Chapter XXXI in The Royal Navy. A History. Boston: Little, Brown. OCLC 46778589.
  • Marley, David F (1998). Wars of the Americas: A Chronology of Armed Conflict in the New World, 1492 to the Present. Santa Barbara, CA: ABC-CLIO. ISBN 9781598841008. OCLC 166373121.
  • Mirza, Rocky M (2007). The Rise and Fall of the American Empire: A Re-Interpretation of History, Economics and Philosophy: 1492–2006. Trafford Publishing. ISBN 978-1-4251-1383-4. Retrieved 14 November 2015.
  • Morris, Richard B (1983) [1965]. The Peacemakers: The Great Powers and American Independence.
  • Morris, Richard Brandon, ed. (1975). John Jay: The winning of the peace: unpublished papers, 1780-1784 Volume 2. Harper & Row. ISBN 9780060130480.
  • O’Shaughnessy, Andrew (2013). The Men Who Lost America: British Command during the Revolutionary War and the Preservation of the Empire. Oneworld Publications. ISBN 9781780742465.
  • Page, Anthony (2014). Britain and the Seventy Years War, 1744-1815: Enlightenment, Revolution and Empire. Macmillan International Higher Education. ISBN 9781137474438.
  • Pratt, Julius William (1971). A History of United States Foreign Policy. Prentice-Hall. ISBN 9780133923162.
  • Reeve, John (16 October 2009). “British naval strategy: war on a global scale”. In Hagan, Kenneth J; McMaster, Michael T; Stoker, Donald (eds.). Strategy in the American War of Independence: A Global Approach. Routledge. ISBN 978-1-134-21039-8.
  • Renaut, Francis P. (1922). Le Pacte de famille et l’Amérique: La politique coloniale franco-espagnole de 1760 à 1792. Paris.
  • Richmond, Herbert W. (1931). The Navy in India 1763–1783. London: Ernest Benn.
  • Rodger, Nicholas A.M. (2005). The Command of the Ocean: A Naval History of Britain, 1649–1815. New York: W.W. Norton.
  • Rogoziński, Jan (1999). A Brief History of the Caribbean: From the Arawak and the Carib to the Present. Facts On File. ISBN 9780816038114.
  • Schiff, Stacy (2005). A Great Improvisation: Franklin, France, and the Birth of America. Thorndike Press. ISBN 978-0-7862-7832-9. Retrieved 24 August 2015.
  • Scott, Hamish M. (1990). British Foreign Policy in the Age of the American Revolution. Clarendon Press. ISBN 978-0-19-820195-3.
  • Simms, Brendan (2009). Three Victories and a Defeat: The Rise and Fall of the First British Empire, 1714-1783. Penguin Books Limited. ISBN 978-0-1402-8984-8.
  • Stockley, Andrew (1 January 2001). Britain and France at the Birth of America: The European Powers and the Peace Negotiations of 1782–1783. University of Exeter Press. ISBN 978-0-85989-615-3. Retrieved 28 August 2015.
  • Stone, Bailey (2014). The Anatomy of Revolution Revisited: A Comparative Analysis of England, France, and Russia. Cambridge University Press. ISBN 9781107045729.
  • Syrett, David (30 June 2007). The Rodney papers: selections from the correspondence of Admiral Lord Rodney. Ashgate. ISBN 978-0-7546-6007-1. Retrieved 16 November 2015.
  • Syrett, David (1998). The Royal Navy in European Waters During the American Revolutionary War. Univ of South Carolina Press. ISBN 978-1-57003-238-7.
  • Regan, Geoffrey (2012). Great Naval Blunders. Andre Deutsch. ISBN 978-0233003504.
  • Tombs, Isabelle; Tombs, Robert (2010). That Sweet Enemy: The British and the French from the Sun King to the Present. Random House. ISBN 9781446426234.
  • Trew, Peter (2006). Rodney and the Breaking of the Line. Pen & Sword Military. ISBN 9781844151431.
  • Tuchman, Barbara (1988). The First Salute: A View of the American Revolution. New York: Knopf. ISBN 0-394-55333-0.

I sold off my entire stock portfolio because of election confusion

I sold off my entire stock portfolio yesterday. I’m not really into stock market investing as it is just one big casino as we wrote about in this article: Exchange Casinos Control Practically Everything You Own.

But with the stock market roaring with Trump in office, it was hard to sit on the sidelines and watch all the gains. I invested a year ago (December 2019) and sold yesterday with a whopping 34% ROI. I only invested because Trump was our president and I knew the economy would be on fire with his America First agenda. But now that the election is under fire, it was time to revisit my current situation.

.

In 2017-18, I played the Crypto Casino, getting in early and exiting with hefty profits. I made enough to pay my taxes and renovate my kitchen, which we call our Bitcoin Kitchen. Today those Bitcoins have exceeded $42,000, yet I have no regrets of getting out when it hit $10,000. But let me tell you…cashing out was a nightmare! They make it easy to invest in cryptos, but hard as heck to pull it out, back into your bank account. If it hadn’t been for the assistance of one of my tech sons, my investment would still be parked in paper wallets.

BTW – You don’t want to take financial advice from me because I don’t hold the government-required credentials to give you financial advice. Funny, my adult children listen to me in financial matters and we have always had great conversations about the economy, money, investing, etc. Several of them think I am a conspiracy theorist, especially the son who is a graduate of War College and thinks he knows more than I do about asymmetrical information warfare, yet he won’t read my blog and has no clue that the British still run America….

.

So this is just your friend Betsy talking over coffee and cheesecake to answer your question, “Betsy, what prompted you to sell everything?”

If Biden squeezes in with the Big Steal, the Great Reset (which is actually a financial crash on all of us little people) will collapse economies all over the world, as planned by the super rich elites who need to cover their massive shorts and since they have nothing in their exhausted coffers and will seize YOUR assets.

You are already seeing the beginning stages of the Great Reset, which is being masked by the plandemic – store closings, commercial real estate vacancies, consumer sales down, and rising unemployment.

Plus, Biden has already said he is rolling out a nationwide mask mandate, mandatory vaccines, and increasing taxes. How will your portfolio perform with a President Biden or Harris?

.

The more likely outcome is that President Trump remains in office, but the companies that support the stock market like Facebook, Google, Apple, and the tech stocks…plus hundreds of big name hedge funds are not going to do well based on our research that they are complicit in foreign election fraud. The foreign interference sanctions enumerated in EO 13848 will be a devastating financial blow to them. Legacy media and social media companies will be gutted for sedition.

Then there is this matter we showed you of all their interlocking directorships that haven’t been reported by Big Name Accounting Firms that could be held liable for these gross omissions in their annual report statements.

Don’t get me started with the huge problems with derivatives and bundled anythings (mortgages, auto loans, insurance.) Derivatives are just straight-up gambling vehicles.

.

Trump had a magic wand on the stock market. You know it; I know it….but does your stock broker know it? What will your portfolio look like when these big companies collapse in the Great Reset, whether a controlled demolition watched over by President Trump or in the hands of Klaus Schwab? Plus, aren’t we sick and tired of being financial patsies for the Rothschilds and the British-American Pilgrims?

In either case, I don’t see the stock market holding. I sold my entire stock portfolio today. What would happen this time if Americans were WOKE to their Ponzi scheme and cashed out of the casino before they knew we were out?

Spread the word to your downline if you think this is something others might want to consider.  

Just sayin’.

.

CRITICAL MUST WATCH.. TOTAL MELTDOWN. By Gregory Mannarino

Surgeon explains the coronavirus hoax

Read the Contagion Myth to learn more and dazzle your downline with how smart you are! Chapter 2 is about electricity and disease and chapter 15 is about 5G.

Why is electricity and 5G a part of the virus conversation, you ask? We explain why in this report below:

The Hidden Dangers of Electricity Are a Mortal Threat to Humanity

Raw audio file: https://aim4truth.org/surgeon-says-masks-do-not-work-mp4/

Continue your citizen education:

Face Masks for the Walking Dead

Face Masks for the Walking Dead

Your Geometry Teacher. (Oct. 21, 2020). Recall your high school geometry and then take off the damn mask. Anonymous Patriots.

See how effortlessly a Coronavirus can pass through the cloth pores of your face diaper?

The face masks are not about health and safety; they are about control, compliance with the ultimate goal of GENOCIDE. Will you and your family be exterminated by Bill Gates vaccines or will you help your children into a boxcar to the nearest FEMA camp for your internment?

You must resist the face mask as though your life depends on it. Make sure your downline understands the gravity of this stage of genocide. Circulate this flyer throughout your network: https://www.fbcoverup.com/docs/library/2020-10-21-Recall-geometry-and-take-off-the-damned-mask-Annoymous-Patriots-Oct-21-2020.pdf

The Oracle-TikTok-Walmart-Zoom-IBM-China ‘Borg’ is Coming After Your 401k

Mike and Doug review the updates made on the Interlocking Organizations chart. Make sure to drop inside and see the expanded version. If you own shares in any of these companies, contact their accounting office and/or investor relations and ask them why they have not disclosed this information to shareholders.

Then, find out who are the company financial auditors for their public annual reports and contact them, in writing, as well. Put all of them on notice that if any of YOUR SHARES go bust, you will sue them for insider trading. You may use this amazing chart that the miners prepared for you:

Interlocking Directorships and Material Beneficial Interests. (Compiled Sep. 21, 2020). Entity Forms DEF 14A: Oracle, TikTok/ByteDance, Zoom, Walmart, IBM Eclipse Foundation, Pilgrims Society. SEC/Anonymous Patriots.

Now drop below and listen to the guys tell you what all of this means. Your 401K could be adversely effected with this network of criminals!

Make sure everyone in your downline gets this critical information.

Raw audio file: https://truthbitsblog.files.wordpress.com/2020/09/wal-mart-ibm-oracle-control-your-401k-1.mp3

We wrote two sample letters for you to send to company auditors and investor relations, putting them on notice that YOU, the SHAREHOLDER, demand to know why they haven’t told you about these interlocking directorships.

Make sure to print the charts and include them in your letters.

Zoom spies on the world for the Pilgrims Society via China

Douglas, Michael, and Tyla explain why Zoom is a dangerous Chinese product designed to surveil Americans at work and play for the benefit of the Highlands Group, communist China, the Pilgrims Society, and the British Imperial Empire.

Raw audio file: https://truthbitsblog.files.wordpress.com/2020/09/zoom-is-chinese-surveillance.mp3

We have been watching with much consternation the roll out of the video conferencing platform called Zoom. Its spectacular rise in popularity has been fueled by the forced imprisonment of citizens in their homes during the COVID false flag operation intended to lock down all humanity in a digital prison planet for the benefit of the Pilgrims Society’s total control of the world.

As their evil always starts, you think it is so nice and convenient. And FREE, too. Everyone in your family can connect by Zoom and have social interactions while being confined to their home imprisonment. Next, Zoom became the online vehicle to run your business meetings. We had a first hand experience of a local court proceeding where we were required to participate by Zoom. No courtroom and bailiff. Just the judge, plaintiff, defendant, and witness all on a Zoom call. Totally unprofessional and spooky, knowing what we do about internet surveillance.

Millions of students across the world have been forced into Zoom classrooms. They sit in front of their computer for the designated class time, all the while being surveiled and observed by who knows what, from who knows where, while being electronically tethered to their device during the set classroom day/time. There have been many reports of pornography just showing up in random picture frames. (We will explain why this happens during our audio discussion.)

And wouldn’t you know it…we found the same nest of swamp rats that we always find in these interlocking relationships and hedge funds.

Just like Tik Tok, ZOOM is a CHINA company.

CHINA is spying on each and every ZOOM call we make. In July 2020, President Trump banned Tik Tok from the United States because if its ties to China.

We need to do the same with Zoom, as well as immediately ban any government use of Zoom in the United States. No government meeting should EVER be conducted over Zoom. China is watching, listening, and recording. Period.

Here’s a look at a component needed to run Zoom. And it just so happens that our team has the experience to explain how this operates and why it gives China a portal into every home, school, office, and Zoom meeting in the world.

.

Read more under this headline link:

Zoom is a China Surveillance Operation

Ohio Citizens Demand Their Civil Rights

New Ohio lawsuit re. COVID hoax

COMPLAINT, Michael Renze et al v. Michael DeWine et al, Case No. 3:20-cv-1948, Judge James G. Carr, filed Sep. 01, 2020  (N.D. Ohio, 2020).

Introduction and Prayer for Relief

Over 110 years ago, at a time when medicine was not yet sufficiently advanced to have developed penicillin and the germ theory of medicine was still new, the Supreme Court of the United States made a ruling related to a citizen’s rights in healthcare that has remained largely unaddressed to this day. Over the century plus of time that has since passed the court has decided many critical cases revolving around individual rights that have never been squared with Jacobson.Jacobson v. Massachusetts, 197 U.S. 11 (1905).

A century ago many of our most sacred and fundamental rights were still being sorted out. Suffrage had not yet occurred, civil rights barely existed, critical cases on fundamental rights such as interstate travel and bodily privacy had not come into play and the administrative state that we live in today simply did not exist.

Today, under the guidance of an unelected administrative structure, many of the rights our Supreme Court has determined are fundamental under our Constitution are being denied. These fundamental rights are being denied, not out of prudence, they are being denied due to unfounded fear and intentional manipulation. So successful is this manipulation that even our esteemed Chief Justice, the Honorable Justice Roberts, was misled in a recent decision.

But all is not lost. In its wisdom, the Jacobsoncourt made clear that it never intended its decision to bar further review. To the contrary, the Court in Jacobsonspecifically stated:“Before closing this opinion, we deem it appropriate, in order to prevent misapprehension as to our views, to observe –perhaps to repeat a thought already sufficiently expressed, namely –that the police power of a State, whether exercised by the legislature or by a local body acting under its authority, may be exerted in such circumstances or by regulations so arbitrary and oppressive in particular cases as to justify the interference of the courts to prevent wrong and oppression.” (Id, 197 US 38)

In recent months, entire states have been imprisoned without due process and with the clear threat to impose such lockdowns again, interstate travel has been severely restricted, privacy rights have been devastated, numerous business takings without compensation, and many regulations being implemented without statutory process requirements under the guise of a health emergency that is roughly as dangerous as a seasonal influenza outbreak. The plaintiffs in this case have all been injured in various capacities by these unconstitutional actions, and without action by the Court, will be left without redress.

More terrifying, without action by the Court, the Court will be setting future precedent that will allow states to withhold fundamental Constitutional rights, in violation of US Supreme Court precedent, circumventing the various levels of scrutiny applied to such rights, and justify such actions under public health emergency orders without subjecting those orders to any real review –just trust the bureaucrats because they are the experts.

We humbly ask the Court in this case to:

  1. Reaffirm its position as a coequal branch of the government.

2. Reaffirm the US Constitution is the supreme law of the land and that rights, especially fundamental rights, may not be abridged unless necessary to serve a compelling governmental interest, and that even then, those restrictions must be narrowly tailored to meet acompelling governmental interest.

3. Ensure there is an opportunity for redress under any emergency declaration

4. Recognize that the political process and operative orders are invalid if based on false or misleading information (cite rule making case in admin law) and recognize the criticality that all future emergency orders be based and maintained on clear, honest facts -particularly when such orders are infringing on Constitutional rights.

Underlying all of this, and the foundation of this case is this question: if an emergency can be declared without the appropriate level of review based on the rights being limited, and under the guise of that emergency all rights are only subject to a rational basis review, how then do any previous judicial opinions or Constitutional principles have any meaning whatsoever?

Further, if under the same circumstances different levels of scrutiny are applied to the various rights being limited under an emergency declaration than would otherwise be applicable, what is the value of having various levels of review?

Read the entire complaint here.

Judicially-Recognized Evidence of British Interference in US 2020 Elections

British Health Minister Matt Hancock MP from a long line of Pilgrims Society globalism

British Health Minister Matt Hancock MP who just trashed anti-vaxxers in Parliament yesterday, Sep. 01, 2020, is teaming with Facebook vice president Sir Nick Clegg to attack anti-vaxxers.

Wife’s family is deeply (British) Pilgrims Society, involved in digital, biological and psychological warfare

Comments in Parliament yesterday are an admission of British government interference in the US 2020 elections.

Here’s the actual UK Parliamentary record that is judicially-recognizable evidence in a court proceeding about direct British interference in U.S. election via Facebook & plan to attack vaccine critics

Hancock’s grandfather-in-law was Baron Frederick Millar, a member of the (British) Pilgrims Society and an enemy of a free American Republic

Matthew John David Hancock, MP [WRITTEN]. (Sep. 01, 2020). Question from MP Chris Elmore (Ogmore) re. starting campaign to tackle anti-vaxxers, Nick Clegg, Facebook, The Secretary of State for Health and Social Care (Matt Hancock), Vol. No. 679, Column 23, 3.35 pm. Hansard UK Parliament. https://bit.ly/3lFMfWj

Matthew John David Hancock, MP [VIDEO]. (Sep. 01, 2020). Question from MP Chris Elmore (Ogmore) re. starting campaign to tackle anti-vaxxers, Nick Clegg, Facebook, The Secretary of State for Health and Social Care (Matt Hancock), Vol. No. 679, Column 23, 3.35 pm. Hansard UK Parliament.

.

Rt Hon Matt Hancock MP

Matt Hancock is the Conservative MP for West Suffolk, and has been an MP continuously since 6 May 2010. He currently holds the Government post of Secretary of State for Health and Social Care.

https://members.parliament.uk/member/4070/portrait

Totally unremarkable lucky sperm career in government:

https://members.parliament.uk/member/4070/career

https://en.wikipedia.org/wiki/Matt_Hancock

Grandfather-in-law was:

https://en.wikipedia.org/wiki/Frederick_Millar,_1st_Baron_Inchyra

Globalist extraordinaire—most assuredly a Pilgrims Society member.

During the Second World War he served chiefly at the British embassy in Washington, where he was also Minister Plenipotentiary from 1948 to 1950. Millar was also the United Kingdom Deputy at the North Atlantic Council from 1950 to 1952 and its Representative thereon from 1952 to 1953. The latter year Millar was appointed High Commissioner to the British Zone of occupied Germany, a post he held until 1955, and was then Ambassador to West Germany from 1955 to 1956. After his return to Britain he served as Permanent Under-Secretary at the Foreign Office from 1957 to 1962.

https://members.parliament.uk/member/4070/contributions#expand-3958322

Has a U. S. Citizen Been Attacked by a Foreign Actor Using an Accelerated Particle Beam?

This is very disturbing because it may be an attack on an American citizen by foreign actors. Ashli has a YouTube channel called the DanjA zonE. We watch her videos for entertaining clips of the royal families. Ashli has a unique colorful “scrapbook” style presentation and has a sizeable audience.

Her topics are tabloid-like, but lately they have been getting more controversial. With over 34 million views, she is hardly ‘not noticed’ by folks researching the royals.

Her titles include:

Queen Says Harry Is Mentally Sick

Ghislaine’s Talkin’, Andrew’s Freakin’ & Harry’s a BUTTHEAD

Meghan, Hillary & Michelle Make Powerful Speech on EMPOWERMENT

Lately we have been concerned for Ashli because her titles are getting “splashier” and closer to the viper’s den of the Pilgrims Society, the Monarch, and the Privy Council. It doesn’t appear that Ashli understands how dangerous the situation is right now. Does she know that Buckingham Palace is boarded up and citizens are rioting outside the gates with chants of P – E – D – O?

“Hey Pedos leave our kids alone” | Protesters chant outside Buckingham Palace

Does she know that the enemy of the planet is located with the Queen and the British Imperial Empire?

The enemy knows that somewhere out here in internet land people are waking up about the royals and their crimes. It would be easy to do an internet search and find Ashli’s hundreds of videos. It would be very easy for the enemy to locate her IP address and, by satellite, launch an accelerated particle beam. Listen to her story and pay careful attention to how the houses burst into flames.

Ashli is having to work through some difficult emotions, but she eventually describes the situation clearly.

THANK YOU TO EVERYONE

.

Now look at the damage done to the home.

UPDATE – THANK YOU SO VERY MUCH

Y’all help this sweet woman out by bringing her situation to light with the authorities who can assist the fire department and fire chief in how these fires originated. We may have been attacked by a foreign actor.

Moderna Insider Trading Reports

Moderna (NASDAQ: MRNA) insider trading reports (Form 4)

CEO Stephan Bancel

Key officers and directors: Sell, Sell, Sell!

https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001682852

Owner Filings Transaction Date Type of Owner
Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer
Zaks Tal Zvi 0001690927 2020-07-27 officer: Chief Medical Officer
Hoge Stephen 0001760669 2020-07-23 officer: President
NABEL ELIZABETH G 0001619929 2020-07-15 director
Tallett Elizabeth E 0001192460 2020-07-01 director
HENDERSON LORI M. 0001221127 2020-06-18 officer: General Counsel and Secretary
Meline David W 0001444612 2020-06-08 officer: Chief Financial Officer
Kim Lorence H. 0001643746 2020-06-02 officer: Chief Financial Officer
AFEYAN NOUBAR 0001222012 2020-05-21 director, 10 percent owner
Flagship Ventures Fund IV, L.P. 0001503559 2020-05-21 10 percent owner
Flagship Ventures Fund IV General Partner LLC 0001508051 2020-05-21 director, 10 percent owner
Flagship Ventures Fund IV-Rx, L.P. 0001590973 2020-05-21 10 percent owner
Andres Juan 0001760670 2020-05-13 officer: See remarks
SAGAN PAUL 0001035440 2020-04-29 director
LANGER ROBERT 0001239757 2020-04-29 director
Nader Francois 0001365343 2020-04-29 director
Horning Sandra 0001638709 2020-04-29 director
Slaoui Moncef 0001712369 2020-04-29 director
Berenson Stephen 0001760671 2020-04-29 director
LEE JENNIFER LING 0001675118 2020-03-09 officer: Chief Accounting Officer

moderna 1

Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer

https://www.fbcoverup.com/docs/library/2020-07-29-Moderna-Stephane-Bancel-CEO-Sold-$31M-shares-SEC-FORM-4-Jul-29-2020.pdf

stephane bancel

Sold $30,840,614 in shares in her name assigned to Boston Biotech, LLC; Bancel children; OCJA LLC (personal LLC); personally

https://www.crunchbase.com/organization/bb-biotech-ventures

A Zurcih, Switzerland company. Guernsey (offshore) based). Martin Munchbach, Managing Director. Bellevue Asset Management AG.

http://www.bbbiotechventures.com/en/bb-biotech-ventures/

Relationships with Sanofi, Roche, Booz Allen, Genencor, Genzyme, Genentech (Rothschild), Novartis, Ciba-Geigy, Glaxo, Seimens, Hoffman-Roche, Harvard,

. . . . . . .

FYI. Ole Stevie boy has been selling his stock out since Nov. 2019.

No buys. All sells.

https://www.fbcoverup.com/docs/library/2020-08-03-Stephane-Bancel-CEO-Moderna-Inc-Form-D-Insider-Trading-Report-SEC-accessed-Aug-03-2020.pdf

bancel stephane

https://yuzuha.substack.com/p/interview-with-moderna-ceo-stephane

. . . . . . .

Moderna’s latest Proxy Statement Form DEF 14A dated Apr. 10, 2020

Massive Wellcome Trust conflict of interest

Includes numerous conflicting relationships with Goldman Sachs, J.P. Morgan, Wellcome Trust (GlaxoSmithKline – GSK), Harvard, UPenn, Stanford, Merck, Novartis, Sanofi, McKinsey, London School of Economics (notorious promoter of communist ideology), Medtronic, MIT, Dell, Roche, Hoffman-Roche, VMware,

Moderna’s CEO Stephane Bancel and Chief Medical Officer Tal Zaks, MD, Phd have been big stock sellers for a year. Zaks was director of clinical development and translational medice for GLAXOSMITHKLINE (Wellcome Trust – co-owner of the Coronavisur Patent along with the Gates Foundation. THIS CONFLICT IS ALONE IS DISQUALIFYING & FRAUDULENT GIVE GLAXO’S RELATIONSHIP WITH THE PIRBRIGHT INSTITUTE (UK). https://heightzone.com/dr-tal-zaks/

Israeli Tal Zaks – Been only selling his Moderna stock (dumping) since Dec. 2019

This guy is evidently dumping his Moderna shares while he is promoting his supposed COVID vaccine.

That is illegal stock manipulation and should land him and his CEO in jail.

C’mon Bill Barr, do your job.

stephane bancel 2

https://www.sec.gov/Archives/edgar/data/1682852/000119312520103908/d915867ddefa14a.htm

Moderna, Inc. (Filer) CIK0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38753 | Film No.: 20787049
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

MANAGEMENT

Executives, non-executive directors and director nominee

The following table sets forth the name, age and position of each of our executives, non-executive directors and director nominee as of March 2, 2020.

Name Age Position
Executives:
Stéphane Bancel (1) 47 Chief Executive Officer and Director
Juan Andres (1) 55 Chief Technical Operations and Quality Officer
Marcello Damiani 50 Chief Digital and Operational Excellence Officer
Tracey Franklin 40 Chief Human Resources Officer
Lori Henderson, J.D. (1) 58 General Counsel and Corporate Secretary
Stephen Hoge, M.D. (1) 44 President
Lorence Kim, M.D. (1) 45 Chief Financial Officer
Tal Zaks, M.D., Ph.D. (1) 54 Chief Medical Officer
Non-Executive Directors:
Noubar B. Afeyan, Ph.D. (4)(5) 57 Chairman, Director
Stephen Berenson (2)(3) 59 Director
Robert Langer, Sc.D. (4) 71 Director
Elizabeth Nabel, M.D. (4)(5) 68 Director
François Nader, M.D.(5) 63 Director
Israel Ruiz(2)(3) 48 Director
Paul Sagan (2)(3) 61 Director
Moncef Slaoui, Ph.D.(5) 60 Director
Director Nominee:
Sandra Horning, M.D. 71 Director nominee
(1) Executive officer
(2) Member of the Audit Committee
(3) Member of the Compensation and Talent Committee
(4) Member of the Nominating and Corporate Governance Committee
(5) Member of the Product Development Committee

These relationships alone should fundamentally disqualify Moderna or any of its INTERLOCKING relationships from any involvement in Coronavirus.

https://www.sec.gov/Archives/edgar/data/1682852/000119312518341958/d611137ds1a.htm

moderna edgar search

.

moderna registration

“Since we nominated our first program in late 2014, we and our strategic collaborators have advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another 3 have open INDs. Our therapeutic and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. We have assembled an exceptional team of approximately 700 employees and have established strategic alliances with leading biopharmaceutical companies, including AstraZeneca, Merck & Co., and Vertex Pharmaceuticals, as well as government-sponsored and private organizations focused on global health initiatives, including Biomedical Advanced Research and Development Authority, or BARDA, Defense Advanced Research Projects Agency, or DARPA, and the Bill & Melinda Gates Foundation. As of September 30, 2018, we have raised over $2.6 billion in total funding from our strategic collaborators and investors, and have cash, cash equivalents, and investments of $1.2 billion. As we unlock the inherent advantages of mRNA, we aim to address as many diseases and impact as many patients as our technology, talent, and capital permit.”

moderna prospectus summary

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022435/xslF345X03/form4.xml

non derivatives securities 1

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022138/xslF345X03/form4.xml

non derivatives securities 2

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022102/xslF345X03/form4.xml

non derivatives securities 3

https://www.sec.gov/Archives/edgar/data/1443340/000112760220022102/xslF345X03/form4.xml

non derivatives securities 4

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021763/xslF345X03/form4.xml

non derivatives securities 5

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021495/xslF345X03/form4.xml

non derivatives securities 6

https://www.sec.gov/Archives/edgar/data/1443340/000112760220021332/xslF345X03/form4.xml

non derivative security 7

https://www.sec.gov/Archives/edgar/data/1443340/000089924320018777/xslF345X03/doc4.xml

non derivatives securities 8

https://www.sec.gov/Archives/edgar/data/1443340/000112760220020892/xslF345X03/form4.xml

non derivatives securities 9

https://www.sec.gov/Archives/edgar/data/1443340/000110465920079182/xslF345X03/a4.xml

non derivatives securities 10

https://www.sec.gov/Archives/edgar/data/1443340/000112760220020206/xslF345X03/form4.xml

non derivatives 11

https://www.sec.gov/Archives/edgar/data/1443340/000112760220019726/xslF345X03/form4.xml

non derivatives 12

https://www.sec.gov/Archives/edgar/data/1443340/000112760220018531/xslF345X03/form4.xml

non derivatives 13

The above screen captures are but a few of 120 SELLS from late 2019 to current

See full list of Stephane Bancel Form 4 insider trading reports

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001443340

Here’s a full list of the Moderna Insiders

https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001682852

moderna insiders

moderna stock exchange

See actual chart entries with hot links above

moderna chart

Bancel Stephane 0001443340 2020-07-29 director, officer: Chief Executive Officer

https://www.fbcoverup.com/docs/library/2020-07-29-Moderna-Stephane-Bancel-CEO-Sold-$31M-shares-SEC-FORM-4-Jul-29-2020.pdf

Sold $30,840,614 in shares in her name assigned to Boston Biotech, LLC; Bancel children; OCJA LLC (personal LLC); personally

https://www.crunchbase.com/organization/bb-biotech-ventures

A Zurich, Switzerland company. Guernsey (offshore) based). Martin Munchbach, Managing Director. Bellevue Asset Management AG.

http://www.bbbiotechventures.com/en/bb-biotech-ventures/

bb biotech

Relationships with Sanofi, Roche, Booz Allen, Genencor, Genzyme, Genentech (Rothschild), Novartis, Ciba-Geigy, Glaxo, Seimens, Hoffman-Roche, Harvard,

.

Executives

Stéphane Bancel has served as our Chief Executive Officer since October 2011 and a member of our board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA (Euronext: BIM). From July 2000 to March 2006, he served in various roles at Eli Lilly and Company (NYSE: LLY), including as Managing Director, Belgium, and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Eli Lilly and Company, Mr. Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux. Mr. Bancel currently serves on the board of directors of Qiagen N.V. (NYSE: QGEN) and previously served on the boards of directors of BG Medicine, Inc. (OTCMKTS: BGMD) and Syros Pharmaceuticals, Inc. (Nasdaq: SYRS). He is currently a Venture Partner at Flagship Pioneering and a trustee of the Museum of Science in Boston. Mr. Bancel holds a Master of Engineering degree from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and an M.B.A. from Harvard Business School. We believe that Mr. Bancel is qualified to serve on our board of directors because of his extensive leadership experience in the healthcare industry and experience as a director of public and private companies.

Juan Andres joined the Company in August 2017, and has served as our Chief Technical Operations and Quality Officer since August 2018. Before joining the Company, Mr. Andres worked at Novartis AG (NYSE: NVS) from

10

Table of Contents

2005 to 2017, in various roles of increasing responsibility including serving as Global Head, Technical Operations (Manufacturing and Supply Chain), Global Head of Quality, and Global Head of Technical Research and Development. From 1987 to 1996, Mr. Andres served in various manufacturing, production, and quality roles at Eli Lilly and Company (NYSE: LLY), including as Vice President, Pharmaceutical Manufacturing. Mr. Andes has served as a member of the board of directors of Evelo Biosciences, Inc. (Nasdaq: EVLO) since December 2019, and of Avantor, Inc. (NYSE: AVTR), since September 2019. Mr. Andres obtained a degree in pharmacy at the Universidad de Alcalá in Spain.

Marcello Damiani joined the Company in May 2015, and has served as our Chief Digital and Operational Excellence Officer since September 2018. From 2009 to 2015, Mr. Damiani held senior roles at bioMérieux (Euronext: BIM), including Senior Vice President and Group Chief Information Officer. Mr. Damiani holds an M.S. degree in Information Systems Architecture from the University of Toulouse, France and completed an international Executive M.B.A. program through TRIUM, an alliance of the London School of Economics, the NYU Stern Business School, and the HEC Paris School of Management, France.

Tracey Franklin has served as our Chief Human Resources Officer since October 2019. From 2004 to October 2019, Ms. Franklin held positions of increasing responsibility at Merck & Co., Inc., including most recently Vice President, HR Chief Talent and Strategy Officer. Ms. Franklin holds a B.A. in communication arts and sciences from Pennsylvania State University and a Masters in industrial and organizational psychology from Fairleigh Dickinson University.

Lori Henderson, J.D., has served as our General Counsel and Corporate Secretary since April 2018. From 2011 to 2018, Ms. Henderson served at Albany Molecular Research Inc. (Nasdaq: AMRI) first as Vice President, General Counsel and Corporate Secretary until 2014 and then as Senior Vice President, General Counsel and Head of Business Development. Prior to her time at AMRI, Ms. Henderson worked as a corporate attorney at Goodwin Procter LLP and as a General Counsel at other corporations. She received her J.D. from the George Washington University Law School and her B.A. in Business and Economics from Gordon College.

Stephen Hoge, M.D., joined the Company in January 2013 and has served as our President since February 2015. From 2010 to 2012, Dr. Hoge was a Partner at McKinsey & Company and a leader in the firm’s healthcare practice. From 2005 to 2010, he served in roles of increasing responsibility at McKinsey & Company. From 2004 to 2005, Dr. Hoge was a resident physician at New York University/Bellevue Hospital. Dr. Hoge has served on the board of directors of Axcella Health, Inc. (Nasdaq: AXLA). He received an M.D. from the University of California, San Francisco and a B.A. in neuroscience from Amherst College.

Lorence Kim, M.D., has served as our Chief Financial Officer since April 2014. From July 2000 to April 2014, Dr. Kim held a number of positions at Goldman, Sachs & Co., most recently as a Managing Director and co-head of biotechnology investment banking. Dr. Kim has served on the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) since 2014. He received an A.B. in Biochemical Sciences from Harvard University, an M.B.A. in Healthcare Management from the Wharton School of the University of Pennsylvania, and an M.D. from the University of Pennsylvania School of Medicine.

Tal Zaks, M.D., Ph.D., has served as our Chief Medical Officer since March 2015. Prior to joining the Company, Dr. Zaks served in senior development positions at Sanofi (NYSE: SNY) from 2010 to 2015, including Senior Vice President and Head of Global Oncology. From July 2008 to May 2010, he served as Vice President of Clinical Research, Oncology at Cephalon. Prior to this, Dr. Zaks spent four years at GlaxoSmithKline (NYSE: GSK) as Director, Clinical Development and Translational Medicine and three years at the National Cancer Institute as a Postdoctoral Fellow. He is currently an Associate Professor of Medicine at the University of Pennsylvania and serves on the board of directors of Adaptimmune Therapeutics plc (Nasdaq: ADAP). Dr. Zaks received his M.D. and Ph.D. from the Ben Gurion University in Israel and conducted post-doctoral research at the U.S. National Institutes of Health. He completed his clinical training in internal medicine at Temple University Hospital followed by a fellowship in medical oncology at the University of Pennsylvania.

11

Table of Contents

Non-executive directors

Noubar B. Afeyan, Ph.D., is a co-founder and has served on our board of directors since incorporation, and has served as a chairman of our board of directors since February 2012. In 1999, Dr. Afeyan founded Flagship Pioneering and serves as its Senior Managing Partner and Chief Executive Officer. Since April 2013, Dr. Afeyan has served on the board of directors of Rubius Therapeutics, Inc. (Nasdaq: RUBY) and since October 2010, on the board of Seres Therapeutics, Inc. (Nasdaq: MCRB). He currently serves on the boards of numerous privately held companies, and has previously served on the boards of numerous privately and publicly held companies, including Evelo Biosciences, Inc. (Nasdaq: EVLO), Kaleido Biosciences, Inc. (Nasdaq: KLDO) and BG Medicine, Inc (OTCMKTS: BGMD). He received a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (“MIT”) and a B.S. in chemical engineering from McGill University. Dr. Afeyan is currently a visiting lecturer of business administration at Harvard Business School and was previously a senior lecturer at MIT’s Sloan School of Management where he taught courses on technology-entrepreneurship, innovation, and leadership. We believe that Dr. Afeyan’s significant experience co-founding, leading, and investing in numerous biotechnology companies make him qualified to serve on our board of directors.

Stephen Berenson has served as a member of our board of directors since October 2017. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan. During his last twelve years at J.P. Morgan, Mr. Berenson was Vice Chairman of Investment Banking and focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. He was co-founder of J.P. Morgan’s Global Strategic Advisory Council and co-founder of the firm’s Board Initiative. Mr. Berenson also serves as Chairman of the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) and on the board of directors of CiBO Technologies, Inc. Mr. Berenson received an S.B. in mathematics from MIT. We believe that Mr. Berenson is qualified to serve on our board of directors because of his experience in the banking and investment industries.

Robert Langer, Sc.D., has served as a member of our board of directors since December 2010. Dr. Langer has been an Institute Professor at MIT since 2005, and prior to that was a Professor at MIT beginning in 1977. Dr. Langer currently serves on the board of directors of Rubius Therapeutics, Inc. (Nasdaq: RUBY), Kala Pharmaceuticals, Inc. (Nasdaq: KALA), and the UK public company Puretech Health plc (LON: PRTC), and previously served on the board of directors of Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), Wyeth (NYSE: WYE), Fibrocell Science, Inc. (Nasdaq: FCSC) and Millipore Corporation (acquired by Merck KGaA in 2010). Dr. Langer also served as a member of the Science Board to the U.S. Food and Drug Administration from 1995 to 2002, including his service as chairman from 1999 to 2002. Dr. Langer received his B.S. from Cornell University and his Sc.D. from MIT, both in Chemical Engineering. We believe that Dr. Langer is qualified to serve on our board of directors because of his pioneering academic work, extensive medical and scientific knowledge and experience, and his previous service on public company boards of directors.

Elizabeth Nabel, M.D., has served as a member of our board of directors since December 2015. Dr. Nabel has served as President of Harvard University-affiliated Brigham Health, which includes Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization, since 2010. Dr. Nabel has also been a Professor of Medicine at Harvard Medical School since 2010. Prior to that, Dr. Nabel held a variety of roles, including Director, at the National Heart, Lung and Blood Institute at the National Institutes of Health, a federal agency funding research, training and education programs to promote the prevention and treatment of heart, lung and blood diseases, from 1999 to 2009. She is an elected member of the National Academy of Medicine of the National Academy of Sciences. Dr. Nabel currently serves on the board of directors of Medtronic plc (NYSE: MDT) and as a trustee of Tekla Capital Management LLC. We believe that Dr. Nabel is qualified to serve on our board of directors because of her extensive experience in the health care field, including senior positions with a number of research universities and organizations.

François Nader, M.D., has served as a member of our board of directors since December 2019. Dr. Nader currently serves as Chairman of the board of directors of Acceleron Pharma Inc. (Nasdaq: XLRN), Prevail

12

Table of Contents

Therapeutics Inc. (Nasdaq: PRVL) and Talaris Therapeutics, Inc. He also serves on the board of directors of Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) and as an advisor for SVB Leerink. Dr. Nader is the past Chairman of BioNJ, New Jersey’s biotechnology trade organization, and previously served on the board of the Biotechnology Industry Organization (BIO), NPS Pharmaceuticals (Nasdaq: NPSP), Advanced Accelerator Applications S.A. (Nasdaq: AAAP), Baxalta Inc. (NYSE: BXLT), Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), Trevena Inc. (Nasdaq: TRVN) and Noven Pharmaceuticals Inc. (Nasdaq: NOVN). Dr. Nader earned his French doctorate in medicine from St. Joseph University in Lebanon and a physician executive M.B.A. from the University of Tennessee. We believe that Dr. Nader is qualified to serve on our board of directors because of his experience in integrated healthcare markets and medical and regulatory affairs and his service on numerous boards of directors.

Israel Ruiz has served as a member of our board of directors since February 2017. Mr. Ruiz has been the Executive Vice President and Treasurer at MIT since 2011. In this role, Mr. Ruiz oversees all principal administrative and financial functions of MIT. Prior to his current role, Mr. Ruiz served as the Vice President for Finance for MIT from 2007 to 2011 and as a principal for MIT’s Office of Budget and Financial Planning from 2001 to 2007. He currently serves on the board of directors of FM Global and previously served on the board of directors of Fortive Corporation (NYSE: FTV). Mr. Ruiz received a degree in industrial and mechanical engineering from the Polytechnic University of Catalonia and a master’s degree from the MIT Sloan School of Management. We believe that Mr. Ruiz is qualified to serve on our board of directors because of his deep financial and accounting experience as the chief financial officer of MIT.

Paul Sagan has served as a member of our board of directors since June 2018. Mr. Sagan has been a Managing Director at General Catalyst Partners, a venture capital firm, since January 2018, and previously served as an Executive In Residence (XIR) since January 2014. From April 2005 to January 2013, Mr. Sagan served as Chief Executive Officer at Akamai Technologies, Inc. (Nasdaq: AKAM) and was President from May 1999 to September 2010 and from October 2011 to January 2013. He was also a director of Akamai Technologies until 2019. Mr. Sagan currently serves on the board of directors of VMware, Inc. (NYSE: VMW) and was a director of EMC from December 2007 until the acquisition by Dell, Inc. in September 2016. Mr. Sagan received his B.S. from the Medill School of Journalism at Northwestern University. We believe that Mr. Sagan is qualified to serve on our board of directors because of his experience and leadership both in the technology and venture capital fields.

Moncef Slaoui, Ph.D., has served as a member of our board of directors since July 2017. Dr. Slaoui joined GlaxoSmithKline Plc (NYSE: GSK) (“GSK”) in 1988, where he engineered the development of a robust vaccines pipeline. He then led worldwide business development for pharmaceutical products before his appointment to lead research and development in 2006. He assumed overall responsibility for GSK’s Oncology Business in 2010, for GSK Vaccines in 2011, and for all Global Franchises in 2012. Dr. Slaoui is Chairman of the board of directors of Galvani Bioelectronics, a company launched in November 2016 that GSK jointly owns with Verily Life Sciences. Dr. Slaoui has advised the U.S. President’s Council of Advisors on Science and Technology, was a member of the Board of the Agency for Science, Technology, & Research until January 2011, the PhRMA Foundation Board from 2008 to 2016, and the Advisory Committee to the Director of the National Institutes of Health from 2011 to 2016. Dr. Slaoui previously served on the board of directors of Intellia Therapeutics Inc. (Nasdaq: NTLA). Dr. Slaoui is also a former Professor of Immunology at the University of Mons, Belgium. Dr. Slaoui received a Ph.D. in Molecular Biology and Immunology from Université Libre de Bruxelles. We believe that Dr. Slaoui is qualified to serve on our board of directors because of his vast experience in the pharmaceutical industry and various leadership positions.

Director nominee

Sandra Horning, M.D., is nominated to serve as a Class II director on our board. Dr. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc., from 2009 until her retirement in 2019. Prior to Roche, Dr. Horning spent 25 years as a practicing oncologist, investigator and tenured professor at the Stanford University School of Medicine, where she remains a professor of medicine emerita. From 2005 to

13

Table of Contents

2006, she served as President of the American Society of Clinical Oncology. From 2015 to 2018, Dr. Horning served on the Foundation Medicine Board of Directors. She currently serves as an advisor to EQRx, Inc. Dr. Horning received her M.D. from the University of Iowa School of Medicine and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University. We believe that Dr. Horning is qualified to serve on our board of directors because of her significant experience in the field of oncology and her product development leadership experience.

. . . . . . .

This financial disclosure is from Moderna’s Initial Public Offering (S-1) disclosure filed on Nov. 09, 2018.

It shows the interlocking and seditious relationships that disqualify ALL of these actors in the current Coronavirus Scam-demic… Gates Foundation, DARPA, BARDA, Merck, AstraZeneca (ICI, British government, Queen’s Golden Share) and Moderna’s Israeli chief medical officer Tal Zaks who was a clinical director at GlaxoSmithKline (Wellcome Trust, agent of the Pilgrims Society and the Queen’s Privy Council)

https://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473ds1.htm

.